ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.

Quote:

Search for Ticker

Free Membership

Search:

EVVV: Ev3 Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

EV3 INC (NASD)
EVVV	12.95	0.12	(0.94%)	Vol. 607,172	16:00 ET

ev3 Inc. is a global medical device company focused on endovascular technologies for the minimally invasive treatment of vascular diseases and disorders.

General Information

EV3 INC

9600 54th Avenue North Suite 100 Plymouth, MN 55442 Phone: 763 398-7000 Fax: 763-398-7200 Web: www.ev3.net Email: jtracy@ev3.net

Industry	MED PRODUCTS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/23/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	12.83
52 Week High	13.39
52 Week Low	4.22
Beta	1.52
20 Day Moving Average	1,135,485.38
Target Price Consensus	14.17

% Price Change
4 Week	8.15
12 Week	-1.18
YTD	106.56

% Price Change Relative to S&P 500
4 Week	6.99
12 Week	-6.83
YTD	70.95

Share Information
Shares Outstanding (millions)	112.10
Market Capitalization (millions)	1,412.46
Short Ratio	3.76
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.12
Current Year EPS Consensus Estimate	0.22
Estimated Long-Term EPS Growth Rate	25.70
Next EPS Report Date	02/23/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.07
30 Days Ago	2.07
60 Days Ago	2.15
90 Days Ago	1.89

Fundamental Ratios

P/E
Current FY Estimate:	57.99
Trailing 12 Months:	48.46
PEG Ratio	2.26

EPS Growth
vs. Previous Year	300.00%
vs. Previous Quarter	27.27%

Sales Growth
vs. Previous Year	5.43%
vs. Previous Quarter:	3.44%

Price Ratios
Price/Book	1.92
Price/Cash Flow	4.52
Price / Sales	3.30

ROE
09/30/09	4.04
06/30/09	0.63
03/31/09	-4.30

ROA
09/30/09	3.50
06/30/09	0.56
03/31/09	-3.89

Current Ratio
09/30/09	2.95
06/30/09	2.76
03/31/09	3.20

Quick Ratio
09/30/09	2.31
06/30/09	2.10
03/31/09	2.44

Operating Margin
09/30/09	6.48
06/30/09	1.10
03/31/09	-8.02

Net Margin
09/30/09	-65.22
06/30/09	-69.52
03/31/09	-77.51

Pre-Tax Margin
09/30/09	-65.22
06/30/09	-69.52
03/31/09	-77.51

Book Value
09/30/09	6.58
06/30/09	6.80
03/31/09	6.04

Inventory Turnover
09/30/09	2.74
06/30/09	2.79
03/31/09	2.64

Debt-to-Equity
09/30/09	0.01
06/30/09	0.01
03/31/09	0.01

Debt to Capital
09/30/09	0.62
06/30/09	0.71
03/31/09	0.90


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research